(Q39981213)

16 September 2017

1 reference

title

The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmias (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

15 March 2023

0 references

0 references

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

15 March 2023

author name string

Bigger JT Jr

1

1 reference

16 September 2017

J. T. Bigger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4892943

15 March 2023

R. H. Heissenbuttel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4892943

15 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4892943

15 March 2023

publication date

1 May 1969

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0033062069900048?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

https://api.elsevier.com/content/article/PII:0033062069900048?httpAccept=text/plain

15 March 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Progress in Cardiovascular Diseases

15 March 2023

published in

1 reference

16 September 2017

11

1 reference

16 September 2017

6

1 reference

16 September 2017

515-534

1 reference

Treatment of acute arrhythmias during anesthesia by intravenous procaine.

16 September 2017

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Comparison of toxicity of intravenously given local anesthetic agents in man.

15 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The intramuscular use of pronestyl (Procaine amide).

15 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

An experimental and clinical study on the effects of procaine amide (pronestyl) on the heart.

15 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The use of procaine amide in cardiac arrhythmias.

15 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Procaine amide (pronestyl) in the treatment of cardiac arrhythmias.

15 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The effect of procaine amide (pronestyl) in clinical auricular fibrillation and flutter.

15 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The response of arrhythmias and tachycardias of supraventricular origin to oral procaine amide

15 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

A study of the effect of procaine amide hydrochloride in supraventricular arrhythmias.

15 March 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The action of procaine amide in cardiac arrhythmias.

15 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Intravenous procaine amide in the treatment of cardiac arrhythmias

15 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Use of pronestyl in the treatment of ectopic rhythms; treatment of 98 episodes in 78 patients.

15 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Recurrent ventricular tachycardia treated with procaine amide.

15 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Procaine amide in the control of cardiac arrhythmias

15 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The current status of procaine amide in the management of cardiac arrhythmias

15 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Ventricular fibrillation precipitated by cardiac catheterization; complete recovery of the patient after 45 minutes

15 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The management of cardiac arrhythmias during cardiac surgery.

15 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Cardiac arrhythmias complicating surgery

15 March 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Aggressive treatment of arrhythmias in acute myocardial infarction: Procedures and results

15 March 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The coronary care unit. New perspectives and directions

15 March 2023

25

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

15 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Use of lignocaine in treatment of cardiac arrhythmias

15 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Antiarrhythmic drugs. Part VII. Lidocaine as an antiarrhythmic agent

15 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT

15 March 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

15 March 2023

Procaine amide; a review

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

On the metabolism of lidocaine. I. The properties of the enzyme system responsible for the oxidative metabolism of lidocaine.

15 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Solubilisation and purification of an amide-hydrolysing microsomal enzyme

15 March 2023

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Central nervous system toxicity induced by lidocaine. Report of a case in a patient with liver disease

15 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

15 March 2023

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The effect of diphenylhydantoin sodium (dilantin), procaine hydrochloride, procaine amide hydrochloride, and quinidine hydrochloride upon ouabain-induced ventricular tachycardia in unanesthetized dogs

15 March 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Direct current shock and lidocaine in the treatment of digitalis-induced ventricular tachycardia

15 March 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The Electrophysiological Properties of Diphenylhydantoin Sodium as Compared to Procaine Amide in the Normal and Digitalis-Intoxicated Heart

15 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The contrasting effects of diphenylhydantoin and procaine amide on A-V conduction in the digitalis-intoxicated and the normal heart

15 March 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Electrophysiological effects of diphenylhydantoin on canine purkinje fibers

15 March 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Appraisal of the effects of catecholamines on cardiac electrical activity.

15 March 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The effects of lidocaine on the electrical and mechanical activity of the heart

15 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

15 March 2023

61

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The action of procaine amide on the heart.

15 March 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Cardiac and peripheral vascular effects of lidocaine and procainamide

15 March 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Hemodynamic changes following procaine amide administered intravenously.

15 March 2023

66

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

THE ANTIARRHYTHMIC PROPERTIES OF LIDOCAINE AND PROCAINE AMIDE. CLINICAL AND PHYSIOLOGIC STUDIES OF THEIR CARDIOVASCULAR EFFECTS IN MAN.

15 March 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Hemodynamic effects of lidocaine in patients with heart disease.

15 March 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Haemodynamic effects of lignocaine in acute myocardial infarction.

15 March 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Electrical reversion of cardiac arrhythmias

15 March 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Antiarrhythmic drugs. VI. Clinical use of procaine amide

15 March 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

FATAL REACTIONS TO LIGNOCAINE.

15 March 2023

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Suppression and initiation of idioventricular automaticity during vagal stimulation.

15 March 2023

74

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Intravenous drug therapy of Stokes-Adams disease; effects of sympathomimetic amines on ventricular rhythmicity and atrioventricular conduction

15 March 2023

75

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

OBSERVATIONS IN PATIENTS WITH IMPLANTED PACEMAKER. 3. FREQUENCY OF VENTRICULAR TACHYCARDIA AS CAUSE OF ADAMS-STOKES ATTACKS AND RATE OF PACING REQUIRED FOR ITS PREVENTION

15 March 2023

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

THE SUPPRESSION OF ARRHYTHMIAS BY ARTIFICIAL PACEMAKING

15 March 2023

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Paroxysmal ventricular tachycardia and fibrillation without complete heart block. Report of a case treated with a permanent internal cardiac pacemaker

15 March 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing

15 March 2023

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Transvenous Atrial Pacing in the Treatment of Refractory Ventricular Irritability

15 March 2023

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

The Control of Ventricular Tachyarrhythmias by Internal Cardiac Pacing

15 March 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Control of recurrent ventricular fibrillation by transvenous pacing in the absence of heart block

15 March 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Rapid intracardiac pacing for treatment of recurrent ventricular tachyarrhythmias in the absence of heart block

15 March 2023

84

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Ventricular standstill during the intravenous procaine amide treatment of ventricular tachycardia.

15 March 2023

88

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Value and hazards of intravenous procaine amide ("pronestyl") therapy.

15 March 2023

89

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Treatment of procaine amide intoxication; an experimental study

15 March 2023

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

A reversal of the cardiotoxic effects of procaine amide by molar sodium lactate

15 March 2023

92

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Prevention of the cardiotoxic effect of quinidine by isoproterenol

15 March 2023

93

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Depression of the heart by quinidine and its treatment

15 March 2023

94

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Procainamide--a Hazard in Myasthenia Gravis

15 March 2023

95

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Allergy to procaine amide.

15 March 2023

96

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Fever due to procaine amide hydrochloride therapy.

15 March 2023

97

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Chills and fever due to procaine amide hydrochloride therapy

15 March 2023

98

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Agranulocytosis following maintenance dosage of pronestyl; report of severe case with recovery.

15 March 2023

99

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Procainamide-induced lupus erythematosus

15 March 2023

101

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH PROCAINAMIDE THERAPY

15 March 2023

102

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

LUPUS-LIKE SYNDROME INDUCED BY PROCAINE AMIDE: ASSOCIATION WITH ANTI-DNA ANTIBODY

15 March 2023

103

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

LUPUS-LIKE ILLNESS PRECIPITATED BY PROCAINAMIDE HYDROCHLORIDE

15 March 2023

104

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Reversible lupus-like illness induced by procainamide

15 March 2023

106

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Lupus-like syndrome induced by procainamide.

15 March 2023

107

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Myotonia, procaine amide, and lupus-like syndrome

15 March 2023

108

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Lupus-like syndrome induced by procainamide

15 March 2023

109

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

15 March 2023

Procainamide toxicity.

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Vasculitis following procaine amide therapy

15 March 2023

111

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Lignocaine for arrhythmias

15 March 2023

112

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Lignocaine for arrhythmias

15 March 2023

113

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Lignocaine for arrythmias.

15 March 2023

114

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

A rare toxic effect of local anaesthesia with lignocaine; a case report.

15 March 2023

116

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

Effects of lidocaine on the central nervous system.

15 March 2023

117

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90004-8

15 March 2023

Identifiers

1 reference

16 September 2017

1 reference